Renalytix plc (RENX) ORD GBP0.0025

Sell:6.50pBuy:7.50pNo change

Prices delayed by at least 15 minutes
Sell:6.50p
Buy:7.50p
Change:No change
Prices delayed by at least 15 minutes
Sell:6.50p
Buy:7.50p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record, or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Key people

Click to see more

Key facts

  • EPIC
    RENX
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    GB00BYWL4Y04
  • Market cap
    £23.18m
  • Employees
    45
  • Shares in issue
    331.21m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.